| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.52 | 0.001 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.52 | 0.07 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.44 | 0.01 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.43 | 0.004 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.4 | 0.003 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.39 | 0.0008 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.36 | 0.005 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.36 | 0.02 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.36 | 0.02 |